Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cyclic Amide-Linked Oxazolidinone Triazoles as Inhibitors of the T-Box Riboswitch

Molecules(2025)10.3390/molecules31010029Source: DataRank Database

Cyclic Amide-Linked Oxazolidinone Triazoles as Inhibitors of the T-Box Riboswitch is a research paper published in Molecules (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Ali H. Aldhumani ORCID,Emily A. Fairchild ORCID,Oluwaseun B. Adegbite,Jessica M. Roberts ORCID,Jennifer V. Hines ORCID

Live enrichment

PubMed:41515326 PMC:PMC12786550 OpenAlex:https://openalex.org/W7116684125

National Institutes of Health

Grant: R15GM132841

National Science Foundation

Grant: CHE-1338000

National Science Foundation

Grant: CHE-1428787

NIH HHS

Grant: 1R15GM132841

FWCI

0.00

Citation Percentile

0.5%

goldLicense: cc-by

journalhttps://www.mdpi.com/1420-3049/31/1/29/pdf?version=1766397687

publisherhttps://www.mdpi.com/1420-3049/31/1/29/pdf?version=1766397687

publisherhttps://www.mdpi.com/1420-3049/31/1/29/pdf

journalhttps://doi.org/10.3390/molecules31010029

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41515326

Fields of Study

RNA and protein synthesis mechanismsRNA modifications and cancerBacterial Genetics and BiotechnologyOxazolidinonesTriazolesRiboswitchMolecular Docking SimulationAnti-Bacterial AgentsAmidesNucleic Acid ConformationRNA, TransferRNA, Bacterial

MeSH Terms

AmidesAnti-Bacterial AgentsNucleic Acid ConformationRNA, BacterialRNA, TransferTriazolesOxazolidinonesRiboswitchMolecular Docking Simulation

Keywords

RiboswitchAllosteric regulationSmall moleculeTranscription (linguistics)Drug discoveryDocking (animal)Bacterial transcriptionAntibacterial agentStructure–activity relationshipRNATriazoleDockingOxazolidinone

Sustainable Development Goals

SDG 0: Good health and well-being